Shi H, Pei L, Gu S, Zhu S, Wang Y, Zhang Y
From deep visceral fat loss to improved sleep, cognitive sharpness, and lean muscle preservation, the potential is huge
Brain Metabolite Changes in Patients With Relapsing-Remitting and Secondary Progressive Multiple Sclerosis: A Two-Year Follow-Up Study
Obesity, affected by both low and high birth weights, is a significant contributor to insulin resistance, dyslipidemia, and hyperinsulinemia, all of which are elements of metabolic syndrome
To this purpose, the present review aims to discuss the advantages and challenges of using standard and cutting-edge techniques to discover salivary biomarkers which may be used in diagnosis/therapy of several chronic diseases with inflammatory consequences with the pursuit to possibly replace conventional paths with detectable soluble mediators in saliva
If anti-Factor Xa levels rise above the expected therapeutic range (peak 1.0 to 4.0 ng/mL for apixaban 5 mg BID, per the FDA label), reduce or discontinue BPC-157 rather than adjusting the apixaban dose
